K99 HL150594/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	3
2021	9
2022	12
2023	4
2024	2

1

Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.

Chaturvedi S, Braunstein EM, Brodsky RA. Chaturvedi S, et al. J Thromb Haemost. 2021 Mar;19(3):607-616. doi: 10.1111/jth.15082. Epub 2021 Feb 10. J Thromb Haemost. 2021. PMID: 32881236 Free PMC article. Review.

2

Counting the cost of caplacizumab.

Chaturvedi S. Chaturvedi S. Blood. 2021 Feb 18;137(7):871-872. doi: 10.1182/blood.2020009250. Blood. 2021. PMID: 33599760 Free PMC article.

3

Race, rituximab, and relapse in TTP.

Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Liu A, Lim MY, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson A, Davis E, Evans MD, Mazepa MA; United States Thrombotic Microangiopathies Consortium. Chaturvedi S, et al. Blood. 2022 Sep 22;140(12):1335-1344. doi: 10.1182/blood.2022016640. Blood. 2022. PMID: 35797471 Free PMC article.

4

Factors mediating cancer risk in systemic lupus erythematosus.

Hardenbergh D, Molina E, Naik R, Geetha D, Chaturvedi S, Timlin H. Hardenbergh D, et al. Lupus. 2022 Oct;31(11):1285-1295. doi: 10.1177/09612033221122163. Epub 2022 Sep 3. Lupus. 2022. PMID: 36059254 Review.

5

How to recognize and manage COVID-19-associated coagulopathy.

Gerber GF, Chaturvedi S. Gerber GF, et al. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):614-620. doi: 10.1182/hematology.2021000297. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889412 Free PMC article. Review.

6

Cardiovascular Disease and Stroke in Immune TTP-Challenges and Opportunities.

Sukumar S, Mazepa MA, Chaturvedi S. Sukumar S, et al. J Clin Med. 2023 Sep 14;12(18):5961. doi: 10.3390/jcm12185961. J Clin Med. 2023. PMID: 37762903 Free PMC article. Review.

7

Complement biomarkers in the antiphospholipid syndrome - Approaches to quantification and implications for clinical management.

Cole MA, Gerber GF, Chaturvedi S. Cole MA, et al. Clin Immunol. 2023 Dec;257:109828. doi: 10.1016/j.clim.2023.109828. Epub 2023 Oct 31. Clin Immunol. 2023. PMID: 37913840 Review.

8

Medical consult: aHUS, TTP? How to distinguish and what to do.

Story CM, Gerber GF, Chaturvedi S. Story CM, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):745-753. doi: 10.1182/hematology.2023000501. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066937

9

Eculizumab for refractory thrombosis in antiphospholipid syndrome.

Hussain H, Tarantino MD, Chaturvedi S, McCrae KR, Roberts JC. Hussain H, et al. Blood Adv. 2022 Feb 22;6(4):1271-1277. doi: 10.1182/bloodadvances.2021005657. Blood Adv. 2022. PMID: 35051999 Free PMC article.

10

Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument.

Kasthuri RS, Chaturvedi S, Thomas S, Vandergrift N, Bann C, Schaefer N, Clancy MS, Pyeritz R, McCrae KR. Kasthuri RS, et al. Blood Adv. 2022 Jul 26;6(14):4301-4309. doi: 10.1182/bloodadvances.2022007748. Blood Adv. 2022. PMID: 35877137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year